Enhancing the Efficacy of Chemotherapeutic Drugs Via Encapsulation within Nanocomplexes Designed to Cross the Blood-Brain Barrier and Target Tumors
<p id="p1">The blood-brain barrier (BBB) blocks ~98% of drugs, so brain tumors tend to be refractory to chemotherapy. Transferrin receptors (TfRs) are expressed on the endothelial cell that comprise the BBB and mediate the movement of transferrin into the brain <em><italic xmlns:mml="http://www.w3.o...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1201034 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Enhancing the Efficacy of Chemotherapeutic Drugs Via Encapsulation within Nanocomplexes Designed to Cross the Blood-Brain Barrier and Target Tumors
- Improving the Efficiency of Chemotherapeutic Drugs by the Action on Neuroepithelial Tumors
- Chemotherapeutic Agent for Glioma
- Environmental Contaminations and Occupational Exposures Involved in Preparation of Chemotherapeutic Drugs
- Blood-Brain Barrier and Effectiveness of Therapy Against Brain Tumors
- Comparative Efficacy of Different Chemotherapeutic Regimens in the Treatment of Peste des Petits Ruminants in West African Dwarf Goats
- Crossing Blood-Brain Barrier with Nano-drug Carriers for Treatment of Brain Tumors: Advances and Unmet Challenges